Sequencing consumables market seen reaching $36.6 billion by 2030

The Business Research Company says the sequencing consumables market reached $12.36 billion in 2025 and is projected to hit $15.66 billion in 2026 before climbing to $36.6 billion by 2030. The report points to genetic disease prevalence, oncology use, and broader adoption of sequencing in clinical and research settings as key growth drivers.

Why it matters: - Sequencing consumables are the reagents, kits and materials that make DNA and RNA sequencing possible. - Demand for these products rises when genomic testing expands in hospitals, research labs and diagnostics. - The market growth signals broader adoption of sequencing in clinical care, oncology and population health.

What happened: - The Business Research Company released a report on the global sequencing consumables market. - The report values the market at $12.36 billion in 2025. - The report projects the market will reach $15.66 billion in 2026. - The report forecasts the market will grow to $36.6 billion by 2030. - The report was distributed from London on Aug. 26, 2026. - A free sample is available here. - The full report is available here.

The details: - The report ties recent growth to genomic research, clinical diagnostics, higher life sciences funding, broader access to sequencing platforms and more consumables use in oncology studies. - The forecast through 2030 is based on stronger demand for personalized medicine, more infectious disease genomics research, wider adoption of third-generation sequencing and higher investment in genomic data analysis. - The report also highlights rising use of sequencing in population health studies. - Expected product trends include greater demand for high-throughput consumables, broader use of next-generation sequencing kits and more specialized reagents for precision diagnostics. - The report points to expansion in platform-specific consumable portfolios and a stronger focus on workflow efficiency and accuracy. - Sequencing consumables support DNA extraction, library preparation, sequencing and analysis. - The products are designed to work with specific sequencing platforms and technologies to help produce accurate and reliable data. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Genetic disease prevalence is becoming a bigger commercial driver as more patients are identified through better diagnostics. - The report cites National Blood Authority data showing 2,788 patients with hereditary haemophilia A in Australia in 2023-2024, up from 2,681 in 2022-2023. - That kind of rise supports broader demand for sequencing tools used to detect disease-linked genetic variants. - North America’s lead reflects stronger research infrastructure and healthcare investment. - Asia-Pacific’s expected growth suggests sequencing adoption is spreading beyond the most mature markets.

What's next: - The report expects the market to keep growing quickly through 2030. - Future demand will likely track personalized medicine, infectious disease genomics and population-scale testing. - The 2026 edition of the report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and market hotspot infographics. - The report also includes updated graphics, tables and future trend analysis.

The bottom line: - Sequencing consumables are moving from a specialized lab input to a core enabler of expanding genomic medicine.